Overview

Detailed Agenda

Speaker

Price/Registration

Venue

Social Media Compliance Issues Related to Drug & Device Manufacturers

The rejection rate of FDA for new drugs and devices for a particlaur use is very high. What most companies do in that case is promote that drug or device off-label. This is not a right practice. It can likely harm the patients and attract lawsuits against you. Your failure to warn users about the probable dangers associated with the use of those drugs might be legally disastrous for you.

According to the legal aspects of product liability, you can’t steer clear of your responsibilities for your failure to warn about off-label consumption. Especially, if you are busy endorsing or marketing the drug or device for that use. You’ll be surprised to know that companies lose millions of dollars and sometimes hundreds of millions every year due to these lawsuits.

Not only, it could cost you your money, job or business, it can also result in your loss of reputation as an individual or as a company.

Evil lies in the widespread ignorance prevalent in the drug and device manufacturing industry. The training they receive is inadequate. An experienced regulatory expert can help you in a big way to save you from the legal fallout of wrongful social media promotion.

Register Online

Who Will Benefit:

This seminar will immensely help compliance officers, executive management, general/corporate counsel, regulatory/legislative affairs professionals, risk management specialist, sales and marketing personnel, training personnel and outside attorneys.


For additional information on the workshop agenda and logistics, please call 410-501-5777 or email: info@fdamap.com